DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Paridaens R, Dirix L, Lohrisch C, Beex L, Nooji M, Cameron D.
Mature results of a randomized phase II multicenter study of exemextane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.
Ann Oncol 2003;
14: 1391-1398
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.